Emcure Pharma To Launch Oral Covid Drug For Emergency Use In India
[email protected]10 Jan, 2022News
Homegrown Emcure Pharmaceuticals Ltd on Friday announced that it has received Emergency Use Authorisation (EUA) approval for the launch of Molnupiravir, an investigational oral anti-viral drug, for the treatment of mild Covid-19. The pharmaceutical company, which has received approval from the Drug Controller General of India, said that it plans to launch Molnupiravir under the brand name Lizuvira in the Indian market.
Related Bookmarks
- Advantages Of Using Sliding Gates Mosman In Businesses
- Performance Testing Learning Which Leads To Growth In Learner�s Career
- Comprehensive Cleaning Solution From Carpet Cleaning Sydney
- Online Classes For LKG in India
- Best Smart LED TV in India | LED TV manufacturers in India
- Wholesale DID
- How Student Tutoring North Shore Helps Students To Prepare For OC Tests
- The Best Advantages Of Auto-Flowering Cannabis Strains
- Organic Skincare Products Online
- Cannabis Seedling Issues And Ways To Resolve The Issues
Recent Profiles
Amanda
Tín Phát Plus
Thaistudents.com Gia Mao
Polartopics
Web Design Valley Llc
Webdesign Groningen
Ps99
Bdtk66
Hu88
Mike Aslan